ALT
Price
$3.79
Change
+$0.08 (+2.16%)
Updated
Aug 29, 01:41 PM (EDT)
Capitalization
327.43M
74 days until earnings call
KLTO
Price
$0.72
Change
-$0.01 (-1.37%)
Updated
Aug 28 closing price
Capitalization
44.47M
Interact to see
Advertisement

ALT vs KLTO

Header iconALT vs KLTO Comparison
Open Charts ALT vs KLTOBanner chart's image
Altimmune
Price$3.79
Change+$0.08 (+2.16%)
Volume$1.07K
Capitalization327.43M
Klotho Neurosciences
Price$0.72
Change-$0.01 (-1.37%)
Volume$845.81K
Capitalization44.47M
ALT vs KLTO Comparison Chart in %
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. KLTO commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Buy and KLTO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ALT: $3.71 vs. KLTO: $0.72)
Brand notoriety: ALT and KLTO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 78% vs. KLTO: 12%
Market capitalization -- ALT: $327.43M vs. KLTO: $44.47M
ALT [@Biotechnology] is valued at $327.43M. KLTO’s [@Biotechnology] market capitalization is $44.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileKLTO’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • KLTO’s FA Score: 0 green, 5 red.
According to our system of comparison, KLTO is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 6 TA indicator(s) are bullish while KLTO’s TA Score has 5 bullish TA indicator(s).

  • ALT’s TA Score: 6 bullish, 2 bearish.
  • KLTO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ALT is a better buy in the short-term than KLTO.

Price Growth

ALT (@Biotechnology) experienced а +5.10% price change this week, while KLTO (@Biotechnology) price change was +6.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.83%. For the same industry, the average monthly price growth was +15.40%, and the average quarterly price growth was +29.55%.

Reported Earning Dates

ALT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (-0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALT($327M) has a higher market cap than KLTO($44.5M). KLTO YTD gains are higher at: 49.381 vs. ALT (-48.544). KLTO has higher annual earnings (EBITDA): -6.8M vs. ALT (-88.03M). ALT has more cash in the bank: 183M vs. KLTO (566K). KLTO has less debt than ALT: KLTO (1.77M) vs ALT (15.8M). ALT has higher revenues than KLTO: ALT (20K) vs KLTO (0).
ALTKLTOALT / KLTO
Capitalization327M44.5M735%
EBITDA-88.03M-6.8M1,294%
Gain YTD-48.54449.381-98%
P/E RatioN/AN/A-
Revenue20K0-
Total Cash183M566K32,332%
Total Debt15.8M1.77M894%
FUNDAMENTALS RATINGS
ALT: Fundamental Ratings
ALT
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALTKLTO
RSI
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 3 days ago
53%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
42%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
32%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 5 days ago
66%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UDOCF0.14N/A
+2.87%
UNIDOC HEALTH CORP.
WEBNF23.880.48
+2.05%
Westpac Banking Corp. Ltd.
SHKLY146.572.22
+1.54%
Sinotruk Hong Kong Ltd.
CELJF9.00-0.20
-2.17%
Cellcom Israel, Ltd.
SHIEF0.10-0.01
-5.21%
Shield Therapeutics PLC

KLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, KLTO has been loosely correlated with CTXR. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if KLTO jumps, then CTXR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLTO
1D Price
Change %
KLTO100%
-0.75%
CTXR - KLTO
36%
Loosely correlated
+2.19%
ANIX - KLTO
33%
Loosely correlated
+2.03%
TAOX - KLTO
24%
Poorly correlated
-5.42%
GUTS - KLTO
24%
Poorly correlated
-0.04%
ALT - KLTO
24%
Poorly correlated
+1.09%
More